Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5865_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
34 Мб
Скачать
Preface
The Applicability Domain (AD) of QSAR models is an important issue to check while predicting a new set of compounds using previously developed QSAR models. AD allows one to estimate the uncer­tainty in the prediction of a particular compound based on how similar it is to the training compounds that are used in the model development. Chapter 5 entitled “Importance of Applicability Domain of QSAR Models” and contributed by Kunal Roy and Supratik Kar defines the concept of applicability
domain of QSAR models. Different approaches of determining AD of QSAR models (based on ranges in the descriptor space, geometry, distance, probability density distribution, and range of the response variable) are elaborated. Some practical examples of the determination of AD are also added. The future
research direction is indicated.
The application of QSAR has been applied to different chemical classes of diverse applications. An­tioxidants are an important class of chemicals with great bio-medicinal importance. Chapter 6 (“QSAR of Antioxidants”), contributed by Omar Deeb and Mohammad Goodarzi, discusses the applications of QSAR in modeling of antioxidant compounds. This chapter starts with an introductory discussion on
antioxidants, their mechanism of action, and methods of determination of antioxidant activity. Then the concepts of QSAR, descriptors and statistical methods and validation strategies are briefly reviewed. Finally, the authors discuss the recent QSAR reports on antioxidants and comment on the structure­antioxidant activity relationships.
Though QSAR was originally developed in the context of physical organic chemistry, it has been
applied very extensively to chemicals (drugs) with action on the biological systems. The applications of QSAR in medicinal chemistry have addressed design and development of potential ligands active against different diseases and health problems. The need for development of new drugs may arise due to emergence of new diseases or reduction of therapeutic efficacy of older candidates in a particular disease condition of increased complexity or emergence of drug resistance. Development of resistance of bacterial pathogens to various antimicrobial agents is an issue of high concern. One of the primary mechanisms of drug resistance is extrusion of the foreign chemical through bacterial efflux pump. To fight against multidrug efflux systems, one possible practice is the combination of conventional anti­microbial agents with small molecules known as multidrug efflux pump inhibitors. Chapter 7 (“QSAR Studies on Bacterial Efflux Pump Inhibitors”), contributed by Khac-Minh Thai, Trong-Nhat Do, Thuy­Viet-Phuong Nguyen, Khanh-Tho D Nguyen, and Thanh-Dao Tran, deals with QSAR modeling studies for bacterial efflux pump inhibitors. The chapter starts with an introduction on antibiotic resistance and role of bacterial efflux pumps in development of the resistance. Then various bacterial efflux pump inhibitors and targets for designing new efflux pump inhibitors are discussed. Finally, QSAR approaches
for the design of new efflux pump inhibitors are presented.
Tuberculosis is a major health problem in the developing countries and second only to Acquired Im­muno Deficiency Syndrome (AIDS) as the notorious killer worldwide due to a single infectious agent.
Chapter 8 (“Integrated in Silico Methods for the Design and Optimization of Novel Drug Candidates: A
Case Study on Fluoroquinolones – Mycobacterium Tuberculosis DNA Gyrase Inhibitors”), contributed by
Nikola Minovski and Marjana Novič, provides a comprehensive overview of some of the current trends and advances in the in silico design of novel drug candidates with a special emphasis on 6-fluoroquino-
lone antibacterials as potential novel Mycobacterium tuberculosis DNA gyrase inhibitors. The authors
start the chapter by presenting a classical industrial drug discovery pipeline followed by a brief mention
xx
EBSCOhost - printed on 2/14/2023 7:16 AM via . All use subject to https://www.ebsco.com/terms-of-use
Preface
of different in silico drug design strategies. Then the authors present a QSAR-aided integrated in silico approach for small-scale ligand screening and virtual combinatorial library design. The authors then present a novel and simple semi-automated Boolean-based clustering method for hit(s) identification. To demonstrate the practical implementation of the suggested integrated in silico screening protocol, the authors present a specific example related to the design and identification of novel 6-fluoroquinolone antibacterials as potential inhibitors against M. tuberculosis DNA gyrase enzyme.
Hepatitis C, a chronic blood-borne virus infection, is a global concern. It is likely that we will see more mortality from this disease in the coming years. Nonstructural 5B (NS5B) polymerase and nonstructural 3/4A (NS3/4a) protease have been found to be promising targets for the development of anti-HCV (Hepa­titis C Virus) agents. In Chapter 9 (“Computational Approaches for the Discovery of Novel Hepatitis C Virus NS3/4a and NS5B Inhibitors”), authored by Khac-Minh Thai, Quoc-Hiep Dong, Thi-Thanh-Lan Nguyen, Duy-Phong Le, Minh-Tri Le and Thanh-Dao Tran, different computational approaches including QSAR and virtual screening for anti-HCV drug discovery are discussed. At the beginning, the authors describe HCV genome, HCV structural and nonstructural proteins. Then the authors briefly introduce various computational modeling techniques, including QSAR, pharmacophore, and docking analyses. The authors then review different applications of QSAR and virtual screening approaches for developing NS5B polymerase inhibitors and NS3/4a protease inhibitors. The QSAR approach in the discovery for multi-target inhibitors of HCV is also described.
Alzheimer’s disease is the most common form of dementia, with chronic, irreversible, and progres­sive neurodegenerative disorder. The acetylcholinesterase enzyme is an important target for development of drugs for the treatment of Alzheimer’s disease. Chapter 10 (“QSAR Models towards Cholinesterase Inhibitors for the Treatment of Alzheimer’s Disease”), authored by C Gopi Mohan and Sikhar Gupta, presents an overview of different QSAR studies carried out for a variety of cholinesterase inhibitors for the treatment of Alzheimer’s disease. In the introduction, the authors discuss Alzheimer’s disease and its etiologies, and then they discuss the structural aspects of the acetylcholinesterase enzyme fol­lowed by an account of different acetylcholinesterase inhibitors. A brief account of theories of QSAR, descriptors, different linear and non-linear modeling methods is then given. Finally, QSAR reports on acetylcholinesterase inhibitors for development of anti-Alzheimer’s drugs are reviewed.
Cancer is a group of diseases that presents a widespread fear in society. There are several forms of cancer that can develop from almost any type of cell in the body. Breast carcinoma is a common form of cancer in females, accounting for about 20% of all cancer-related deaths. Being overexpressed in breast cancer and responsible for estrogen production, aromatase is a potential target for designing anti-breast cancer drugs. Chapter 11 (“Ligand- and Structure-Based Drug Design of Non-Steroidal Aromatase Inhibitors [NSAIs] in Breast Cancer”), authored by Tarun Jha, Nilanajn Adhikari, Amit Kumar Halder, Chanchal Mondal, and Achintya Saha, discusses the design of nonsteroidal aromatase inhibitors using QSAR and receptor-based approaches. In the Introduction of the chapter, the authors discuss breast cancer and its treatments. Then the authors highlight biochemistry, structure, and gene expression of aromatase. The authors then mention different types of aromatase inhibitors. Finally, in silico modeling studies of aromatase inhibitors using both ligand- and structure-based approaches are reviewed.
Predictive toxicology is an important area of application of QSAR. With any amount of resources avail­able, it is impossible to experimentally evaluate the toxicity potential of tens of thousands of compounds against all available toxicity endpoints. Then it becomes necessary to rely on the validated computational models for risk assessment of industrial and other chemicals. Chapter 12 (“Computational Techniques
EBSCOhost - printed on 2/14/2023 7:16 AM via . All use subject to https://www.ebsco.com/terms-of-use
xxi
Preface
Application in Environmental Exposure Assessment”), authored by Karolina Jagiello and Tomasz Puzyn,
presents an overview of the application of computational techniques in environmental exposure assessment.
In the Introduction, the authors highlight the importance of computational toxicology in the light of REACH
regulations. Then the authors briefly introduce the QSAR methodology and validation tools. Multimedia mass-balance modeling and QSAR modeling for the environmental exposure assessment are described. A novel method linking multimedia mass-balance and QSAR are also commented on. The authors finally give their opinion on future possibilities of computational techniques for environmental exposure assessment.
Apart from drug discovery and predictive toxicology, the QSAR principles have also been applied in material science. Different properties and activities of various types of materials have been modeled using quantitative structure-property relationships. Nanotechnology is a newly emerging field in the
st
century. Nanomaterials have tremendous application potential in medicine, cosmetics, electron-
21 ics, biomaterials, and energy production. However, the toxicity of nanomaterials to living organisms and the environment still remains relatively unknown. Thus, it is necessary to evaluate the potential adverse effects of nanomaterials to humans and the environment. Chapter 13 (“QSAR-Based Studies of Nanomaterials in the Environment”), authored by Valeria V. Kleandrova, Feng Luan, Alejandro Speck­Planche, and M. Natália D. S. Cordeiro, provides an overview of in silico approaches for the prediction of environmental toxicity of nanomaterials. At the beginning, the authors focus on the environmental risk of nanomaterials. Then the authors review in silico studies of environmental effects of nanomaterials
including classical type QSAR models and perturbation models. The authors also present a case study of unified QSAR-perturbation model, demonstrating its ability to predict ecotoxicity of nanoparticles under diverse experimental conditions.
We have another contributed chapter on the computational risk assessment of nanomaterials. In Chapter 14 (“Quantitative Nanostructure-Activity Relationship Models for the Risk Assessment of NanoMaterials”), authored by Eleni Vrontakia, Thomas Mavromoustakos, Georgia Melagraki, and Antreas Afantitis, recent studies on predictive quantitative nano-structure activity relationship models for the risk assessment of nanomaterials are reviewed. The authors initially discuss the impact of nano­technological innovations in modern society. The authors then indicate the need to evaluate the toxicity potential of nanomaterials. With a brief introduction to the basic workflow of QSAR modeling, the
authors review QSAR reports on nanomaterial toxicity. The authors also give their opinion on the future of computational nanotoxicology.
QSAR practitioners have to rely on the software tools for developing validated and predictive models
for possible application on new sets of data. Thus, access to validated software tools is a prerequisite for QSAR research in the present-day scenario. Most of the useful software tools are commercial, while only few tools are available free. Chapter 15 (“QSPR/QSAR Analyses by Means of the CORAL Software: Results, Challenges, Perspectives), authored by Andrey A. Toropov, Alla P. Toropova, Emilio Benfenati, Orazio Nicolotti, Angelo Carotti, Karel Nesmerak, Aleksandar M. Veselinović, Jovana B. Veselinović, Pablo R. Duchowicz, Daniel Bacelo, Eduardo A. Castro, Bakhtiyor F. Rasulev, Danuta Leszczynska, and Jerzy Leszczynski, presents a freeware tool, CORAL, for QSAR model development. The authors at first introduce some basic concepts of QSAR followed by a discussion on the technical details of CORAL. Then the authors discuss several QSAR/QSPR studies made using the CORAL software reported over the past few years. Finally, the authors indicate some problems associated with the CORAL software and mention the future directions.
xxii
EBSCOhost - printed on 2/14/2023 7:16 AM via . All use subject to https://www.ebsco.com/terms-of-use
Preface
In the above 15 chapters, different aspects of theory and applications of QSAR and recent develop­ments are discussed. This book covers the basic principles and tools used in QSAR (Chapter 1), novel descriptors (Chapters 2, 3, and 4), tests for applicability domain (Chapter 5), applications of QSARs for optimization of structures of bioactive compounds (Chapter 6), modeling of drug candidates for potential therapeutic targets in the context of drug discovery (Chapters 7-11), risk assessment of chemicals in the context of environmental safety (Chapter 12), evaluation of toxicity of nano-materials in the context of nano-science (Chapters 13 and 14), and novel software tools for application in QSAR studies (Chapter
15). I hope that this book will attract researchers in the field of medicinal chemistry and predictive toxicology both in the industry and academia.
Kunal Roy Jadavpur University, India November 10, 2014
EBSCOhost - printed on 2/14/2023 7:16 AM via . All use subject to https://www.ebsco.com/terms-of-use
xxiii
xxiv

Acknowledgment

I am grateful to the members of the Editorial Advisory Board and the external reviewers for their help in developing this book. I am also thankful to Prof. L. B. Kier of Virginia Commonwealth University for writing the Foreword of this book. I also thank the authors for their contributions and the Publisher for taking an initiative for bringing out this book.
Kunal Roy Jadavpur University, India November 10, 2014
EBSCOhost - printed on 2/14/2023 7:16 AM via . All use subject to https://www.ebsco.com/terms-of-use
Chapter 1
An Introduction to the
Basic Concepts in QSAR-
Aided Drug Design
Maryam Hamzeh-Mivehroud
Biotechnology Research Center & School of Pharmacy, Tabriz University of Medical Sciences,
Tabriz, Iran
Babak Sokouti
Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
1
Siavoush Dastmalchi
Biotechnology Research Center & School of Pharmacy, Tabriz University of Medical Sciences,
Tabriz, Iran
ABSTRACT
The need for the development of new drugs to combat existing and newly identified conditions is unavoid­able. One of the important tools used in the advanced drug development pipeline is computer-aided drug design. Traditionally, to find a drug many ligands were synthesized and evaluated for their effectiveness using suitable bioassays and if all other drug-likeness features were met, the candidate(s) would possibly reach the market. Although this approach is still in use in advanced format, computational methods are an indispensable component of modern drug development projects. One of the methods used from very early days of rationalizing the drug design approaches is Quantitative Structure-Activity Relationship (QSAR). This chapter overviews QSAR modeling steps by introducing molecular descriptors, mathemati­cal model development for relating biological activities to molecular structures, and model validation. At the end, several successful cases where QSAR studies were used extensively are presented.
DOI: 10.4018/978-1-4666-8136-1.ch001
Copyright © 2015, IGI Global. Copying or distributing in print or electronic forms without written permission of IGI Global is prohibited.
EBSCOhost - printed on 2/14/2023 7:16 AM via . All use subject to https://www.ebsco.com/terms-of-use
An Introduction to the Basic Concepts in QSAR-Aided Drug Design
INTRODUCTION
Drug design and discovery is a multidimensional task necessitating collaboration across a broad range of disciplines and areas of research. Computational drug discovery is an essential component in drug design process that accelerates drug discovery and development by providing useful preliminary infor­mation at the early stages of the process. Quantitative structure-activity relationship (QSAR) is one of the effective data mining strategies of the computational approaches which have opened up a number of informative perspectives in modern and profitable drug design process. The chapter will focus on rational drug design and the importance of relevant computational approaches in this area. Moreover, the chapter will introduce the QSAR studies as a part of computational methods in drug design and development processes. Different kinds of molecular descriptors, data analysis, descriptor selection, model building and evaluation will be discussed. Application of QSAR studies by providing some specific case studies will also be highlighted.
BACKGROUND
Drugs are vital, essential, and inevitable part of our life which is always being threatened by different diseases. Therefore, administration of safe and effective drugs is necessary. According to the side effects being reported in clinic, finding novel drugs with minimum toxicity is always a need. Drug discovery is a patient-oriented, complex, and time consuming process associated with spending huge amount of investment and involves many experts from different disciplines such as biology, biochemistry, pharma­cology, mathematics, computing and molecular modeling. It has been estimated that of 9.000-10.000 new chemical entities identified or synthesized, one can reach the market within an average time of 16 years. Previously, drugs have been discovered either by identifying chemicals by trial-and-error or by serendipity. Today, attempts have been focused on rational drug design. Its fundamental principle lies in logical reasoning before synthesizing any therapeutic agent for the evaluation. In this context, computer-assisted drug design is a valuable and promising tool in rational drug design and discovery pipeline and plays an important role in pharmaceutical research by reducing the costly failures of drug candidates in clinical trials.
One of the strong appeals of QSAR studies deals with chemical safety and risk of toxicity. Toxicologi­cal profile and safety assessment of new chemical entities is of paramount importance in drug design and development process. Compounds with improved biological activity do not necessarily reach the market and most of them are discarded from clinical trials just for toxicity concerns. Therefore, toxic­ity is a major source of attrition for potential drug candidates. Drug toxicity and safety assessment of chemicals is time consuming and is accompanied with spending millions of dollars. In this context, structure-toxicity predictive models of pharmaceutically relevant molecules can provide an estimation of risk assessment and safety of drug candidates and it can be regarded as a promising and fundamental way to reduce the need for animal testing as well as ethical and monetary cost. As a consequence, poten­tially toxic compounds can be identified during early stages of drug discovery process. Carcinogenicity, mutagenicity, teratogenicity, hepatotoxicity, cardiotoxicity, and nephrotoxicity are the most important endpoints in toxicity evaluation (Sullivan, Manuppello, & Willett, 2014; Toropov, Toropova, Raska, Leszczynska, & Leszczynski, 2014).
2
EBSCOhost - printed on 2/14/2023 7:16 AM via . All use subject to https://www.ebsco.com/terms-of-use
An Introduction to the Basic Concepts in QSAR-Aided Drug Design
Computational approaches can be classified into structure-based drug design (SBDD), ligand-based drug design (LBDD) and sequence-based approaches (Ou-Yang et al., 2012). In the presence of experi­mentally determined structure of target molecule, molecular docking and de novo drug design can be used in the SBDD procedures. In situations in which three dimensional (3D) structure of target mol­ecule is not available, LBDD methods are applied. Quantitative structure-activity relationship (QSAR), molecular field analysis, pharmacophore modeling, and 2D/3D similarity assessment are examples of these methods. In the absence of information regarding target and ligand molecules, sequence-based approaches based on bioinformatics tools are utilized to ultimately find a solution to the drug develop­ment problem which may fit in one of the two previously mentioned categories.
QSAR methodology covers data analysis and statistical methods for developing models with capability of predicting the biological and toxicological activities of compounds based on their structures. It was first introduced by Corwin H. Hansch (Hansch, Maloney, Fujita, & Muir, 1962). The basic principle of the technique relies on building mathematical relationship between biologi­cal/toxicological activity data of a series of compounds and their structures defined by molecular descriptors. Molecular descriptors are numerical representations of molecular structures derived from steric, electronic, constitutional, topological, and geometrical properties of the molecules. Descriptors used in QSAR hold information about a molecule either as a whole or distinct parts of it. These descriptors can be experimentally measured or calculated using theoretical methods. Having descriptors in hand, those with biological relevance should be selected. Different descriptor selection methods, aimed to determine the best descriptor subset from a large pool of descriptors, have been proposed to reduce the number of descriptors present in the final mathematical QSAR model for explaining the biological activities of the studied molecules. These methods can be classified in three common categories including classical, artificial intelligence based, and miscel­laneous methods that are necessary for generalization of predicted QSAR model through training steps. Multiple linear regression (MLR) analysis and partial least squares (PLS) are the examples of linear methods whereas artificial neural networks (ANNs) and the k-nearest neighbours (k-NNs) are few examples for non-linear methods. Generally, linear models predict the biological activity in a linear function and these models are also easy to interpret compared with non-linear models. Although, the classical methods can model the linear relationships between structural properties and biological activities, however, they are not effective in developing models where the relationships are non-linear. Therefore, in these cases, the descriptor selection methods based on artificial intel­ligence can easily map existing non-linear relations between structural properties represented by descriptors and their corresponding biological activity faster and with higher reliability than classical methods because of their non-linear architecture. As QSAR methods are predictive modeling tools, the important criterion for evaluating their reliability and validity is to assess the capability of the models to predict not only the biological activity of the molecules included in training set (internal validation) but also for the molecules not involved in generating the model (external validation). Leave-one-out (LOO) and leave-group-out (LGO) are commonly utilized methods for internal cross validation whereas for external validation method, the predictivity of the QSAR model is judged based on a separate set of molecules called test set which are not included in model development in any stage. QSAR has served as a valuable predictive tool for identifying hit compounds, predict­ing the biological/toxicological activity of untested pharmaceuticals as well as optimizing the lead compounds for improving the biological activity (shown in Figure 1).
EBSCOhost - printed on 2/14/2023 7:16 AM via . All use subject to https://www.ebsco.com/terms-of-use
3
An Introduction to the Basic Concepts in QSAR-Aided Drug Design
G
Figure 1. Pyramid of different steps in QSAR procedure
BIOLOGICAL ACTIVITY DATA
One of the essential constituents of QSAR analysis is biological activity of the compounds under inves­tigation. It is defined as quantitative measurement of the changes brought about by any chemical entity in the biological process which can provide numerical assessment of potency (Jackson, Esnouf, Winzor, & Duewer, 2007). Experimental determination of precise and accurate biological activities is of great importance for generating a meaningful model as they affect the whole process of modeling down the way substantially. Biological activity obtained from a set of biological assays, should be performed with great care and evaluated by appropriate statistical treatment to the required satisfaction, e.g., doing the experiments in triplicates or doublet of triplicates due to response variations. A typical bioassay com­prises two components including compound and target of interest like an enzyme, isolated receptors, animal tissue, cell based assays, and so on. Different kinds of biological and toxicological activities are used for QSAR studies including affinity data (substrate/receptor binding constant); rate constants such
as association/dissociation and Michaealis Menten constants ( and
IC50; in vitro and in vivo pharmacokinetic and pharmacodynamic rate constants, lethal dose (LD50)
just to mention a few (Kubinyi, 1993). For QSAR analysis, equilibrium/rate constants are well suited as
; G RT K
they are related to Gibbs free energy (
= −2 303. log ;Keq is the equilibrium con-
stant). Therefore, the biological activity should be used in logarithmic scale to fulfill the linear free­energy relationship (LFER) criteria. The other reason is the normal distribution of the errors of the activity values when they are presented in the logarithmic scale. Sometimes, the logarithm of reciprocal biological activity is preferred to use as higher values obtained for potent analogs. The range of bio-
Kd andKm); inhibition constants like Ki
eq
4
EBSCOhost - printed on 2/14/2023 7:16 AM via . All use subject to https://www.ebsco.com/terms-of-use
An Introduction to the Basic Concepts in QSAR-Aided Drug Design
logical activity is important while developing the QSAR models. Full spectrum of activity is required for a data set and should range at least 3 to 4 orders of magnitude difference between the most and the least potent compounds. The larger the range, the more reliable QSAR model can be achieved (Scior et al., 2009). The compounds with poor activity should be incorporated in developing a predictive QSAR model. However, remotely isolated rare activities may be problematic by causing biases in the developed model. Since, the data for biological activity are crucial in generating accurate and valid QSAR model, therefore too much attention should be paid as they are not always as good as they seem at first sight.
CHEMICAL STRUCTURE REPRESENTATION
There are several different ways of representing chemical structures including 2D and 3D representa­tions. 2D structures specify elements, connectivity, and bond order whereas Cartesian coordinates for each atom is determined in 3D formats. Encoding approaches for 2D representations are line notations, connection tables and molecular graphs. Line notations are appeared as a sequence of atoms connected by compact linear string of alphanumeric symbols. The most commonly used line notations are described as follows. Simplified Molecular Input Line Entry System (SMILES; see Figure 2) is widely used for­mat of notation implemented by Daylight Chemical Information Systems (Santa Fe, NM) (Weininger, 1988; Weininger, Weininger, & Weininger, 1989). SYBYL Line Notation (SLN) developed by Tripos Inc. provides richer set of information for molecular queries, stereochemistry, and reactions (Figure 2). The other line notation introduced recently is InChI stands for IUPAC international chemical identifier. This format of representation provides a unique line notation consisting of six layers, each identifying a distinctive structural property about the molecule. The layers are main layer, a charge layer, stereochemi­cal layer, an isotopic layer, a fixed-H, and a reconnected layer. The presence of main layer, which speci­fies atom and bond types, is required but the others are optional (Warr, 2011; Young, 2009). The other molecular line notations are Wiswesser Line-Formula Notation (WLN) and representation of structure diagram arranged linearly (ROSDAL). Figure 2 shows different line notation formats for phenylalanine as an example (Warr, 2011).
Connection tables are the other types of encoding style, in which the chemical structure is defined as a table of atom and bond types connecting the atoms with given arbitrary number in a series. Relative coordinates for each atom are usually included. An example of most commonly used connection table in Molfile format is shown in Figure 3.
Registry systems like Chemical Abstract Service Registry Number (CAS RN) are database of dis­closed chemical substance information. Although it is a method of naming structures and provides no chemical information, however, it can be converted to machine readable structures by several programs
2
such as ACD/Labs Germany) (Warr, 2011).
The other method for representing the chemical structures in 2D format is the molecular graph. Molecular graphs are derived from the graph theory; a theory not only used in chemistry but also in computer and related sciences. This theory is a branch of mathematics that defines the sets of objects by nodes and the corresponding relationships between them called edges. Atoms and bonds are considered as nodes and edges, respectively, in a molecular graph. For a molecular graph some properties like atom type (for nodes) and bond order (for edges) can be represented. Generally, the molecular graph shows the topology of the molecule and the way the atoms are connected (Figure 4).
(Toronto, Canada), CambridgeSoft3 (Cambridge, MA), and InfoChem4 (Munich,
1
EBSCOhost - printed on 2/14/2023 7:16 AM via . All use subject to https://www.ebsco.com/terms-of-use
5